anti clotting drugs Flashcards
Name the type of anti clotting drugs
- antiplatelets
- anti coagulants
- anti thrombin
Name the classes of antiplatelet drug
- NSAID : aspirin
- platelet GPIIa/b receptors blocker
- ADP blocker
- PDE inhibitor
Aspirin MOA
inhibit cyclooxygenase, inhibit conversion of arachidonic acid into prostaglandin
Aspirin clinical uses
- prophylaxis for cerebral ischemia
- prevent recurrent myocardial infarction
Aspirin adverse effects
- GI bleeding and ulcers
- bruising and bleeding
What are GPIIa/b receptors
- platelet membrane surface proteins
- mainly for fibrinogen
- activation of receptor complex is the final common pathway of platelet aggregation
Name 3 platelet GPIIa/b receptor blockers
ATE
1. Abciximab : humanised monoclonal ab
2. Tirofiban: small molecule blocker
3. Eptifibatide
Platelet GPIIa/b receptor blockers clinical uses
prevent restenosis
used for acute coronary syndrome
Name 2 ADP receptor blockers
- clopidogrel
- ticlopidine
ADP receptor blockers MOA
prevents ADP from binding to ADP receptor, prevent activation of platelets
Name a PDE inhibitor
dipyridamole
Dipyridamole MOA
- inhibits phosphodiesterase
- prevents breakdown of cAMP
- increase levels of cAMP in platelets
- decrease platelet aggregation and adhesion
Name the anticoagulants
- heparin
- wafarin
- anti thrombin III
Heparin MOA
- heparin binds to ATIII, causing conformational change to ATIII active site, exposing it to the enzyme (thrombin factor IIa)
- heparin is also required to bind to the protease to inhibit thrombin
- inhibit conversion of fibrinogen to fibrin
- prevent clotting
Heparin clinical uses
- deep vein thrombosis
- pulmonary embolism
- actue myocardial infarction
- can be used in pregnancy
Heparin bioavailability
- given IV/ subcutaneous
given IM during haematomas
Heparin adverse effect
- thrombocytopaenia
- haemorrhage
- stop heparin and use protamine sulfate (antidote for heparin)
Warfarin MOA
- inhibit vitamin K reductase: convert vit K into its active form
(vit K is essential for formation of clotting factors 2,9,10,12) - reduce vit K available in liver
- decrease activation of clotting factors
warfarin clinical uses
same as heparin
CANNOT BE USED IN PREGNANCY
wafarin adverse effects
- bleeding
- cross placenta and cause haemorrhagic disorder in fetus
- hep clearance by cytochrome P450 : DDI!!!!
Name 4 thrombolytic agents
- tissue plasminogen activator (alteplase)
- urokinase
- streptokinase
- anistreplase
thrombolytic agents MOA
- activate plasminogen into its active form plasmin
- plasmin cleaves fibrin which is the main component of the clot
thrombolytic agents bioavailability
- IV injection
- intracoronary injection
thrombolytic agent clinical uses
- emergency treatement of coronary artery thrombosis
- peripheral arterial thrombosis and emboli
- ischaemic stroke (<4.5 h)
thrombolytic agent adverse effects
- bleeding
- impaired wound healing
- contraindicated in pregnancy